A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors ...
Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...
In a new study published in Science Translational Medicine, investigators have shown that HIV can acquire mutations that cause resistance to lenacapavir—but at a huge cost to the virus itself.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results